This is a brand page for the EXOCORRECT trademark by Evox Therapeutics Limited
in *********, **********, ***** ****.
Write a review about a product or service associated with this EXOCORRECT trademark.
Or, contact the owner Evox Therapeutics Limited of the EXOCORRECT trademark by filing a request to communicate with
the Legal Correspondent for licensing, use, and/or questions related to the EXOCORRECT trademark.
On Friday, July 23, 2021,
a U.S. federal trademark registration was filed for
EXOCORRECT.
The USPTO has given the EXOCORRECT
trademark serial number of 79330721.
The current federal status of this trademark filing is NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED.
The correspondent listed for EXOCORRECT is
J A Kemp LLP of
********,********, ***** ****
.
The EXOCORRECT trademark is filed in the category of
Pharmaceutical Products
,
Computer & Software Services & Scientific Services
,
Medical, Beauty & Agricultural Services
.
The description provided to the USPTO for EXOCORRECT
is Pharmaceuticals; pharmaceutical preparations and substances; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for therapeutic use; pharmaceutical preparations, namely, exosomes to deliver protein or nucleic acids or viral vectors for therapy; medicine; medical preparations and articles; biological preparations for medical purposes; biological preparations for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint/ligament strain/tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism (IEMs), lysosomal storage disorders and urea cycle disorders; biological preparations comprising exosome; biological preparations comprising a therapeutic target protein-loaded, nucleic acid-loaded or virus-loaded exosome; biological reagents for medical use; mixed biological preparations for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, EV-based nucleic acid therapeutics for the prevention and treatment of infections or disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint/ligament strain/tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism (IEMs), lysosomal storage disorders and urea cycle disorders.